Published in:
01-12-2018
Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties?
Authors:
Christian A. Koch, Siegfried Krabbe, Bernd Hehmke
Published in:
Reviews in Endocrine and Metabolic Disorders
|
Issue 4/2018
Login to get access
Abstract
The immune system is closely intertwined with the endocrine system. Many effects of medications used for various clinical endocrine conditions such as the metabolic syndrome, hypercholesterolemia, diabetes mellitus, hypertension, Graves’ disease and others also have an impact on the immune system. Some drugs including statins, metformin, angiotensin converting enzyme and proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones are known to have immunomodulatory properties. We here review the literature on this topic and provide some clinical examples including the use of statins in Graves’ orbitopathy, rheumatoid arthritis, multiple sclerosis, and adult-onset Still’s disease. In that context, we introduce a special immunodiagnostics method developed at the Institute of Diabetes “Gerhardt Katsch” in Karlsburg, Germany, to not only measure but also monitor immune disease activity.